Starke Amends Flora Growth Stake Filing

TL;DR

Starke updated his 13D filing for Flora Growth (FLGC) on 9/11, event date 8/14.

AI Summary

Clifford Starke, through an amendment filed on September 11, 2024, has updated his Schedule 13D filing concerning Flora Growth Corp. The filing indicates a change in the date of the event requiring the statement to August 14, 2024. Starke is listed with a mailing address at Flora Growth Corp. in Fort Lauderdale, Florida.

Why It Matters

This amendment updates the filing requirements for significant shareholders, providing transparency on ownership changes and potential influence over Flora Growth Corp.

Risk Assessment

Risk Level: low — This is a routine amendment to a Schedule 13D filing, not indicating new material events or significant shifts in holdings.

Key Numbers

• 20240911 — Filing Date (Date the amendment was filed with the SEC)
• 20240814 — Event Date (Date of the event requiring the filing)

Key Players & Entities

• Clifford Starke (person) — Filing person
• Flora Growth Corp. (company) — Subject company
• Pia Porras (person) — Associated person
• Richard Raymer (person) — Attorney for filing person
• Dorsey & Whitney LLP (company) — Law firm

FAQ

Key Financial Figures

• $0.95 — the Issuer's Common Stock at a price of $0.95 per share. Item 5. Interests in Securi

Filing Documents

• 13da4.htm (SC 13D/A) — 24KB
• image0.jpg (GRAPHIC) — 3KB
• 0000912282-24-000638.txt ( ) — 30KB

. Source and Amount of Funds or Other Consideration

Item 3 . Source and Amount of Funds or Other Consideration PF and OO

Purpose of Transaction

Item 4. Purpose of Transaction On December 15, 2023, the Issuer issued 1,028,665 stock appreciation rights ("SARs") to the Reporting Person, subject to forfeiture absent shareholder approval at the Issuer's next annual meeting. On May 27, 2024, the Issuer granted 575,319 SARs to the Reporting Person, subject to shareholder approval at the Issuer's next annual meeting. On August 14, 2024, the shareholders approved the December 15, 2023 and May 27, 2024 grants of SARs. The SARs vest in 12 equal installments, subject to Issuer share price criteria, have a ten-year term, and a post-termination exercise price of one year. The 473,995 common shares held directly by the Reporting Person and the 565,714 common shares held indirectly through Hampstead Private Capital Limited have been transferred to YT Research Inc., a company in which the Reporting Person is the sole director and equity owner. On September 5, 2024, the Reporting Person purchased 51 shares of the Issuer's Common Stock at a price of $0.95 per share.

Interests in Securities of the Issuer

Item 5. Interests in Securities of the Issuer: As of September 5, 2024, the Reporting Person holds the following shares of Common Stock: (a) Number of shares as to which the Reporting Person has: (i) Sole power to vote or to direct the vote: 2,944,091 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or direct the disposition: 2,944,091 (iv) Shared power to dispose or direct the disposition: 0 (v) Aggregate amount of shares beneficially owned: 2,944,091 (vi) Percent of class represented in Item (v) above: 19.7%

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer Stock Appreciation Rights Agreement

Materials to be Filed as Exhibits

Item 7. Materials to be Filed as Exhibits Exhibit 10.1 Stock Appreciation Rights Agreement incorporated by reference as Exhibit 10.1 to the Issuer's Form 8-K filed with the Securities and Exchange Commission on September 5, 2024 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: September 11, 2024 /s/ Dany Vaiman as attorney-in-fact for Clifford Starke Clifford Starke

View Full Filing

View this SC 13D/A filing on SEC EDGAR